Successful application of prime and pull strategy for a therapeutic HSV vaccine

One promising approach for a herpes simplex virus vaccine uses a vaccine to prime and a chemoattractant to pull immune cells into the genital tract. We evaluated subunit vaccines (prime) and imiquimod (pull) in the guinea pig (gp) model of recurrent Herpes simplex virus type-2 (HSV-2). Following vag...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernstein, David I., Cardin, Rhonda D., Bravo, Fernando J., Awasthi, Sita, Lu, Peiwen, Pullum, Derek A., Dixon, David A., Iwasaki, Akiko, Friedman, Harvey M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6671986/
https://www.ncbi.nlm.nih.gov/pubmed/31396405
http://dx.doi.org/10.1038/s41541-019-0129-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6671986/
https://www.ncbi.nlm.nih.gov/pubmed/31396405
http://dx.doi.org/10.1038/s41541-019-0129-1

Ejemplares similares